Could hookworm saliva lead to a new treatment for type 2 diabetes? 15 September 2021 Sometimes medical breakthroughs appear in the most unexpected forms and that’s why researchers are hopeful that the humble hookworm could hold the key to a new diabetes treatment. Researchers at James Cook University and Macrobiome Therapeutics believe the anti-inflammatory properties of the creature’s saliva may help prevent or delay the development of type 2 diabetes. “If the project is successful and we come up with a drug [for diabetes] inspired by parasitic worms … that will be a game changer, ” molecular parasitologist Dr Alex Loukas said. Studies in developing countries found that people who took deworming medication to remove parasites became more susceptible to conditions like diabetes. “Parasitic worms secrete all sorts of compounds that have anti-inflammatory properties to stop your immune system from flushing [the worms] out,” he said. Hookworms are also being studied for other purposes, such as using their larvae to treat gluten intolerance and coeliac disease, and genetically modifying hookworms to protect frontline soldiers from chemical and biological threats. “There is something in these [parasitic] infections that can prevent the onset of these types of diseases and our goal now is to try to distil those in molecular medicine.” Researchers hope to conduct preclinical studies (the testing stage before human trials) within the next five years. Key Findings Researchers are working to develop a new drug for type 2 diabetes by determining what therapeutic properties hookworm saliva has. Hookworms are also being studied for other purposes, such as treating gluten intolerance and coeliac disease, and protecting soldiers from biological and chemical threats. Researchers hope to conduct preclinical studies for drugs derived from hookworms within the next five years.
Blog 5 December 2023 Top 10 articles for 2023 Perhaps unsurprisingly the top stories during 2023 were related to the availability, or otherwise, of medications. The nationwide shortage of... Continue Reading
Blog 4 December 2023 Are you up to date with your COVID-19 vaccination? As we head into the festive season it's a good time to make sure you are up-to-date with your COVID-19 vaccination. Continue Reading
Media releases 24 November 2023 New vitamin C diabetes research announced Deakin University’s Professor Glenn Wadley is a recipient of one of this year’s Diabetes Australia Research Program (DARP) grants to study the efficacy of vitamin C in the treatment of foot ulcers in people living with diabetes, which can lead to amputations. Continue Reading